231 related articles for article (PubMed ID: 34061202)
21. Assessment of Clinician Decision-making on Cancer Screening Cessation in Older Adults With Limited Life Expectancy.
Schoenborn NL; Massare J; Park R; Boyd CM; Choi Y; Pollack CE
JAMA Netw Open; 2020 Jun; 3(6):e206772. PubMed ID: 32511720
[TBL] [Abstract][Full Text] [Related]
22. Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020.
Pirsl F; Keruly JC; Moore RD; Lau B; Joshu CE
Prev Med; 2024 Jul; 184():108000. PubMed ID: 38735585
[TBL] [Abstract][Full Text] [Related]
23. Effect of a Mammography Screening Decision Aid for Women 75 Years and Older: A Cluster Randomized Clinical Trial.
Schonberg MA; Kistler CE; Pinheiro A; Jacobson AR; Aliberti GM; Karamourtopoulos M; Hayes M; Neville BA; Lewis CL; Wee CC; Fagerlin A; Nekhlyudov L; Marcantonio ER; Hamel MB; Davis RB
JAMA Intern Med; 2020 Jun; 180(6):831-842. PubMed ID: 32310288
[TBL] [Abstract][Full Text] [Related]
24. Cancer Screening Patterns Among Current, Former, and Never Smokers in the United States, 2010-2015.
Sanford NN; Sher DJ; Butler S; Xu X; Ahn C; D'Amico AV; Rebbeck T; Aizer AA; Mahal BA
JAMA Netw Open; 2019 May; 2(5):e193759. PubMed ID: 31099863
[TBL] [Abstract][Full Text] [Related]
25. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
[TBL] [Abstract][Full Text] [Related]
26. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
Drazer MW; Huo D; Eggener SE
J Clin Oncol; 2015 Aug; 33(22):2416-23. PubMed ID: 26056181
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
[TBL] [Abstract][Full Text] [Related]
28. Factors Related to Prostate-Specific Antigen-Based Prostate Cancer Screening in Primary Care: Retrospective Cohort Study of 120,587 French Men Over the Age of 50 Years.
Rat C; Schmeltz H; Rocher S; Nanin F; Gaultier A; Nguyen JM
JMIR Public Health Surveill; 2018 Oct; 4(4):e10352. PubMed ID: 30355559
[TBL] [Abstract][Full Text] [Related]
29. Patient-Reported Factors Associated With Older Adults' Cancer Screening Decision-making: A Systematic Review.
Smith J; Dodd RH; Gainey KM; Naganathan V; Cvejic E; Jansen J; McCaffery KJ
JAMA Netw Open; 2021 Nov; 4(11):e2133406. PubMed ID: 34748004
[TBL] [Abstract][Full Text] [Related]
30. Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.
Hattangadi JA; Chen MH; D'Amico AV
BJU Int; 2012 Dec; 110(11):1636-41. PubMed ID: 22757982
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies.
Cho H; Klabunde CN; Yabroff KR; Wang Z; Meekins A; Lansdorp-Vogelaar I; Mariotto AB
Ann Intern Med; 2013 Nov; 159(10):667-76. PubMed ID: 24247672
[TBL] [Abstract][Full Text] [Related]
32. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study.
Hoffman RM; Koyama T; Albertsen PC; Barry MJ; Daskivich TJ; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Potosky AL; Penson DF
J Gen Intern Med; 2015 Jul; 30(7):924-34. PubMed ID: 25678374
[TBL] [Abstract][Full Text] [Related]
33. Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Loomans-Kropp HA; Pinsky P; Cao Y; Chan AT; Umar A
JAMA Netw Open; 2019 Dec; 2(12):e1916729. PubMed ID: 31800071
[TBL] [Abstract][Full Text] [Related]
34. Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending.
Kim DD; Daly AT; Koethe BC; Fendrick AM; Ollendorf DA; Wong JB; Neumann PJ
JAMA Netw Open; 2022 Nov; 5(11):e2243449. PubMed ID: 36413364
[TBL] [Abstract][Full Text] [Related]
35. Variation in prostate-specific antigen screening in men aged 80 and older in fee-for-service Medicare.
Bynum J; Song Y; Fisher E
J Am Geriatr Soc; 2010 Apr; 58(4):674-80. PubMed ID: 20345867
[TBL] [Abstract][Full Text] [Related]
36. Targeting of mammography screening according to life expectancy in women aged 75 and older.
Schonberg MA; Breslau ES; McCarthy EP
J Am Geriatr Soc; 2013 Mar; 61(3):388-95. PubMed ID: 23414437
[TBL] [Abstract][Full Text] [Related]
37. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
Zanwar P; Lin YL; Kuo YF; Goodwin JS
BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
[TBL] [Abstract][Full Text] [Related]
39. Cancer Screening of Older Adults in Israel According to Life Expectancy: Cross Sectional Study.
Bareket R; Schonberg MA; Comaneshter D; Schonmann Y; Shani M; Cohen A; Vinker S
J Am Geriatr Soc; 2017 Nov; 65(11):2539-2544. PubMed ID: 28875497
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
